Last reviewed · How we verify
GLP-1 analogue
GLP-1 analogue is a Small molecule drug developed by Tanabe Pharma Corporation. It is currently FDA-approved.
GLP-1 analogues are small molecule medications used to treat conditions such as Type 1 diabetes, hyperlipidemias, and obesity. They are administered as an intervention to help manage these conditions, although the exact mechanism of action is not specified in the provided facts.
At a glance
| Generic name | GLP-1 analogue |
|---|---|
| Sponsor | Tanabe Pharma Corporation |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Effect of Agonist GLP1 on Adipose Tissue in Patients Undergoing Bariatric Surgery (NA)
- DECODE - Haemodynamic Effects Of Semaglutide and Tirzepatide - a Series of Pilot Studies (PHASE4)
- Study on the Efficacy and Safety of PLLA Injections for Improving Facial Laxity Following GLP-1 Analog Therapy (NA)
- Direct Measurement of Microstructure of Ingestive Behaviour After Initiation of GLP-1 Receptor Agonist Treatment at Maximum Dose (DIGRAT)
- Efficacy and Safety of PJ009 in Patients With Short Bowel Syndrome Requiring Parenteral Nutrition (PHASE3)
- The Effect of an Anti-obesity Drug, Semaglutide, as Treatment in New-onset Idiopathic Intracranial Hypertension (IIH) Compared to Standard Weight Management (Dietician) With Regards to Change in Weight and Intracranial Pressure (PHASE4)
- Investigating the Impact of GLP-1 RA Therapy on Osteosarcopenia in Older Female Adults With Diabetes (PHASE3)
- GLP-1 Analogue in Preventing Progression of Small Vessel Disease (GAPP-SVD) (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- GLP-1 analogue CI brief — competitive landscape report
- GLP-1 analogue updates RSS · CI watch RSS
- Tanabe Pharma Corporation portfolio CI
Frequently asked questions about GLP-1 analogue
What is GLP-1 analogue?
Who makes GLP-1 analogue?
What development phase is GLP-1 analogue in?
Related
- Manufacturer: Tanabe Pharma Corporation — full pipeline
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing